As for clinical manifestations, we found only 1 patient with ocular symptoms, ie, an incidence of symptomatic disease of 0.27% in the whole candidemic population. Moreover, ocular candidiasis progressed favorably in all except 1 of our evaluable patients, who was asymptomatic and did not experience vision loss. These findings are consistent with those recently reported by Oude Lahof, who observed visual symptoms in only 3.3% of patients with ocular candidiasis and a favorable outcome in almost all evaluable cases . Older studies reporting ocular candidiasis as a "malignant complication" were performed in an era when medical management of candidemia differed substantially from contemporary care [1–5, 24–26]. Furthermore, a high proportion of patients included in such studies had a history of intravenous drug use  that was not observed in our series.